| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.442 | 13.970 | 16.953 | 27.872 | - | 35.103 | 21.314 |
| Total Income - EUR | - | - | - | 7.442 | 25.629 | 16.953 | 27.872 | - | 35.103 | 48.293 |
| Total Expenses - EUR | - | - | - | 6.469 | 14.606 | 21.967 | 14.074 | - | 62.351 | 71.401 |
| Gross Profit/Loss - EUR | - | - | - | 973 | 11.023 | -5.013 | 13.797 | - | -27.248 | -23.108 |
| Net Profit/Loss - EUR | - | - | - | 750 | 10.355 | -5.507 | 13.092 | - | -27.547 | -24.140 |
| Employees | - | - | - | 1 | 0 | 0 | 0 | - | 1 | 1 |
Check the financial reports for the company - Path - Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 31.809 | 26.845 | 22.071 | 19.297 | - | 20.060 | 11.589 |
| Current Assets | - | - | - | 3.028 | 1.803 | 1.640 | 13.805 | - | 37.851 | 1.621 |
| Inventories | - | - | - | 1.592 | 450 | 1.951 | 3.067 | - | 28.352 | 0 |
| Receivables | - | - | - | 1.012 | 598 | -856 | 4.522 | - | 5.105 | 466 |
| Cash | - | - | - | 424 | 756 | 545 | 6.216 | - | 4.394 | 1.155 |
| Shareholders Funds | - | - | - | 793 | 11.133 | 5.414 | 18.386 | - | 11.529 | 1.088 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | - | 40 | 40 |
| Debts | - | - | - | 34.044 | 17.516 | 18.296 | 14.716 | - | 46.382 | 13.369 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Path - Med S.r.l.